From the Wayne State University Division of Research media release: More than one million people in the United States are afflicted with Parkinson’s disease, a progressive disorder of the brain that affects movement and coordination. The…
From the American Osteopathic Association media release: Researchers from the Rowan University School of Osteopathic Medicine are nearing development of a blood test that can accurately detect the presence of Alzheimer’s disease, which would give physicians…
From the Rutgers University media release: Can you imagine a drug that would make it easier to learn a language, sharpen your memory and help those with dementia and Alzheimer’s disease by rewiring the brain and…
From the Rockefeller University media release: A new class of drugs under development to treat depression has shown some success by targeting brain cells’ ability to respond to the chemical messenger glutamate. But the mechanism by…
From the NIH/National Institute of Neurological Disorders and Stroke media release: Scientists at the National Institutes of Health discovered that reactivation of ancient viral genes embedded in the human genome may cause the destruction of neurons…
From the Tohoku University media release: Researchers from Tohoku University’s Research Institute of Electrical Communication and RIKEN BSI have found the presence of neurons in the human brain which can each selectively respond to an intermediate…
From the Center for BrainHealth media release: How scientists study the effects of marijuana on the brain is changing. Until recently marijuana research largely excluded tobacco users from its participant pool, but scientists at the…
From the Institute for Basic Science media release: The burgeoning field of optogenetics has seen another breakthrough with the creation of a new plant-human hybrid protein molecule called OptoSTIM1. In South Korea, a research team led…
From the Elsevier media release: The latest issue of Biological Psychiatry presents the results of three studies implicating metabotropic glutamate receptor 2 (mGluR2) as a new molecular target for the treatment of addiction. Group II metabotropic…
From the Ludwig-Maximilians-Universitaet Muenchen (LMU) media release: Alzheimer’s disease is associated with the appearance of characteristic neurotoxic protein aggregates in various regions in the brain. Chemical analysis of these insoluble deposits reveals that they are made…